Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

One clinical trial site activatedPatient enrollment expected in AprilTrial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of ...

daily aspirin therapy cut the risk of a first heart attack by a third. In women, daily aspirin therapy reduced the rate of strokes by 17%. Certain conditions increase the likelihood of heart ...

Aspirin prevents blood clots by stopping thrombocytes ... “Most immunotherapies are developed to treat patients with established metastatic cancer, but when cancer first spreads, there’s a unique ...

Researchers have been exploring this link for decades. The first clinical study, published in 1988, showed that regular aspirin use significantly lowered the risk of colorectal cancer, though the ...

completed its first Good Manufacturing Practice Clinical Batch of its pharmaceutical-grade oral mucosal formulation of aspirin that utilizes Aspire’s fast-acting formulation. Aspire’s GMP ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And Development ...